News & Events

Press Releases

On the 28th March 2022, OncoArendi changed its name to Molecure

OncoArendi executes the strategy for 2021-2025 in the area of R&D platform for developing small molecules modulating RNA function

16 June 2021

OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis

5 November 2020

American Journal of Medicinal Chemistry distinguishes OncoArendi publication on OATD-01

21 October 2020

OncoArendi Therapeutics expands the therapeutic potential of its Chitinase Platform

13 October 2020

OncoArendi Therapeutics broadens its collaboration with VIB, a leading life science research institute in Europe, to investigate the role of chitinase family of proteins as potential therapeutic targets in COVID-19 patients

11 September 2020

OncoArendi Therapeutics has received the final report from the phase Ib clinical trial of innovative drug candidate OATD-01

10 September 2020

Sign up for the latest News & Events

Events & Presentations

Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada

27 February 2020

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

11 September 2019

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

4 September 2019

ATS- International Conference – Dallas, 17-22.05.2019

22 May 2019

EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018

17 September 2018

EFMC – International Symposium on Medicinal Chemistry – Ljubljana 02-06.09.2018

17 September 2018
This site is registered on wpml.org as a development site.